Payment overview · 2025
General Payments
$1,038.88
14 reported records · 3 companies
Healthcare provider profile · identity verified
Nancy C Turnham, DNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · DOTHAN, AL · NPI 1023087228
Verified facts
What the public records show
CMS Open Payments records show Nancy C Turnham, DNP received $1,038.88 in general payments during 2025 across 14 reported records.
SCPHARMACEUTICALS INC. accounted for 58.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SCPHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $608.93 | 58.6% | 11 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $225.75 | 21.7% | 2 | 2025 |
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $204.20 | 19.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $1,038.88 | 14 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FUROSCIX Normalized: furoscix |
Drug | SCPHARMACEUTICALS INC. | $608.93 | 11 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $225.75 | 2 | 2025 |
Source payment records
|
|||||
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $204.20 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 449 | 42 |
| Amlodipine Besylate | Amlodipine Besylate | 398 | 62 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 389 | 29 |
| Levothyroxine Sodium | Levothyroxine Sodium | 384 | 60 |
| Potassium Chloride | Potassium Chloride | 374 | 72 |
| Atorvastatin Calcium | Atorvastatin Calcium | 323 | 60 |
| Gabapentin | Gabapentin | 285 | 43 |
| Furosemide | Furosemide | 278 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 278 | 59 |
| Eliquis | Apixaban | 258 | 30 |
| Losartan Potassium | Losartan Potassium | 255 | 43 |
| Tamsulosin Hcl | Tamsulosin Hcl | 243 | 38 |
| Donepezil Hcl | Donepezil Hcl | 235 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 208 | 42 |
| Divalproex Sodium | Divalproex Sodium | 196 | 32 |
| Lisinopril | Lisinopril | 193 | 39 |
| Duloxetine Hcl | Duloxetine Hcl | 188 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 172 | 27 |
| Metoprolol Succinate | Metoprolol Succinate | 171 | 25 |
| Mirtazapine | Mirtazapine | 171 | 37 |
| Carvedilol | Carvedilol | 164 | 29 |
| Tramadol Hcl | Tramadol Hcl | 161 | 37 |
| Trazodone Hcl | Trazodone Hcl | 161 | 37 |
| Sertraline Hcl | Sertraline Hcl | 153 | 30 |
| Risperidone | Risperidone | 146 | 21 |
| Memantine Hcl | Memantine Hcl | 143 | 24 |
| Buspirone Hcl | Buspirone Hcl | 141 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 129 | 26 |
| Levetiracetam | Levetiracetam | 123 | 15 |
| Xarelto | Rivaroxaban | 123 | 13 |
| Alprazolam | Alprazolam | 122 | 24 |
| Mounjaro | Tirzepatide | 110 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 103 | 14 |
| Lorazepam | Lorazepam | 100 | 31 |
| Meloxicam | Meloxicam | 95 | 19 |
| Metformin Hcl | Metformin Hcl | 93 | 19 |
| Warfarin Sodium | Warfarin Sodium | 91 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 85 | suppressed |
| Lactulose | Lactulose | 82 | suppressed |
| Latanoprost | Latanoprost | 77 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 75 | 14 |
| Nystatin | Nystatin | 71 | 23 |
| Ozempic | Semaglutide | 71 | 13 |
| Estradiol | Estradiol | 63 | 11 |
| Omeprazole | Omeprazole | 63 | 21 |
| Allopurinol | Allopurinol | 60 | 13 |
| Np Thyroid | Thyroid,pork | 59 | suppressed |
| Bumetanide | Bumetanide | 58 | 13 |
| Finasteride | Finasteride | 58 | suppressed |
| Fluconazole | Fluconazole | 58 | 27 |
| Olanzapine | Olanzapine | 58 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 55 | 26 |
| Ondansetron Hcl | Ondansetron Hcl | 55 | 40 |
| Simvastatin | Simvastatin | 55 | 13 |
| Pregabalin | Pregabalin | 54 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 53 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 53 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 52 | 29 |
| Baclofen | Baclofen | 52 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 51 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 48 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 48 | 14 |
| Zenpep | Lipase/Protease/Amylase | 48 | suppressed |
| Clonazepam | Clonazepam | 47 | suppressed |
| Entresto | Sacubitril/Valsartan | 47 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 47 | 11 |
| Securesafe Pen Needle | Pen Needle, Diabetic, Safety | 47 | 22 |
| Divalproex Sodium Er | Divalproex Sodium | 43 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 41 | suppressed |
| Prednisone | Prednisone | 41 | 16 |
| Cephalexin | Cephalexin | 40 | 17 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 40 | suppressed |
| Trulicity | Dulaglutide | 40 | suppressed |
| Aripiprazole | Aripiprazole | 39 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 39 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 38 | suppressed |
| Diazepam | Diazepam | 37 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 37 | 14 |
| Digoxin | Digoxin | 36 | suppressed |
| Levofloxacin | Levofloxacin | 36 | 29 |
| Carbamazepine Er | Carbamazepine | 34 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 34 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 33 | suppressed |
| Sucralfate | Sucralfate | 33 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Topiramate | Topiramate | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Azithromycin | Azithromycin | 29 | 19 |
| Hydromorphone Hcl | Hydromorphone Hcl | 29 | suppressed |
| Rexulti | Brexpiprazole | 29 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 28 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 26 | 11 |
| Midodrine Hcl | Midodrine Hcl | 26 | 11 |
| Spironolactone | Spironolactone | 26 | suppressed |
| Temazepam | Temazepam | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Atenolol | Atenolol | 24 | suppressed |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 19 |
| Xifaxan | Rifaximin | 24 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 23 | suppressed |
| Linzess | Linaclotide | 23 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Neupro | Rotigotine | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 21 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 21 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 20 | suppressed |
| Cefdinir | Cefdinir | 20 | 16 |
| Letrozole | Letrozole | 20 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 14 |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 19 | suppressed |
| Famotidine | Famotidine | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Nystop | Nystatin | 18 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 17 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 17 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 17 | 11 |
| Ketoconazole | Ketoconazole | 16 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 16 | suppressed |
| Zonisamide | Zonisamide | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 15 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 15 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Armour Thyroid | Thyroid,pork | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Otezla | Apremilast | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Mupirocin | Mupirocin | 13 | 12 |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 12 | 11 |
| Metronidazole | Metronidazole | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,038.88 · 14 records | SCPHARMACEUTICALS INC. | FUROSCIX, LifeVest, Zunveyl | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error